The use of molecular markers in selecting therapy for CLL.
Döhner
Hartmut
H
Department of Internal Medicine III, University of Ulm.
D014408:Biomarkers, Tumor / Q000096:biosynthesis / Q000235:genetics; D002869:Chromosome Aberrations; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D009154:Mutation; D011379:Prognosis
D014408:Biomarkers, Tumor